TMCnet News

Market Research Reports, Inc. (www.marketresearchreports.com): MarketResearchReports.Com: Obesity - Pipeline Review, H1 2014, New Report Launched
[July 28, 2014]

Market Research Reports, Inc. (www.marketresearchreports.com): MarketResearchReports.Com: Obesity - Pipeline Review, H1 2014, New Report Launched


(M2 PressWIRE Via Acquire Media NewsEdge) Market Research Reports, Inc. has announced the addition of "Obesity - Pipeline Review, H1 2014" research report to their website http://www.marketresearchreports.com This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obesity and special features on late-stage and discontinued projects.



The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope - - The report provides a snapshot of the global therapeutic landscape of Obesity - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Obesity and enlists all their major and minor projects - A review of the Obesity products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - Coverage of the Obesity pipeline on the basis of target, MoA, route of administration and molecule type Reasons to Buy - - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Obesity pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


Browse this report: http://mrr.cm/ZeX About Market Research Reports, Inc.

Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Contact Us: Mr. Amitava Sen Vice President - Sales & Marketing Market Research Reports, Inc.

Tel USA: +1-302-703-7787 Tel India: +91-80-26860858 For Pharma Reports: http://www.linkedin.com/company/pharmaceuticals For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter ( Market Research Reports, Inc. ) .

(c) 2014 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]